Media Cybernetics Image-Pro Premier 2D Image Analysis Software v9.3
01 February, 2018 | Supplied by: SciTech Pty LtdImage-Pro Premier, by Media Cybernetics, is a 2D image analysis software package that offers intuitive tools that make it easy to capture, process, count, measure, analyse and share images and valuable data.
Visualising employment trends in biomedical science
25 January, 2018US researchers have developed a tool that helps newly trained scientists evaluate various career paths, separating employment trends in biomedical science by sector, type and job specifics.
VR allows scientists to 'walk' together through cancer cells
20 December, 2017Virtual reality technology is allowing multiple scientists to see inside a human cell at the same time, giving researchers a 3D tool to improve doctor interaction and help analyse how cancer drugs work.
Computer algorithms identify cancer from tissue images
19 December, 2017Artificially intelligent computer algorithms have been found to equal human pathologists in detecting metastases of breast cancer in lymph nodes.
Personalised seizure prediction made possible with AI
18 December, 2017Australian epilepsy researchers have used a mobile, brain-inspired processor to bring personalised seizure prediction a step closer to a reality.
When the cat's away, the mice will train
13 December, 2017 by Lauren DavisSeeking to move neuroscience research into the fast lane, researchers at the RIKEN Brain Science Institute have constructed and deployed a high-throughput system to study mouse behaviour and physiology at a much faster rate than that achieved via manual methods.
Computer simulations reveal roots of antibiotic resistance
08 December, 2017Supercomputer simulations have revealed the role of transport proteins called efflux pumps in creating drug resistance in bacteria — a breakthrough that could help improve drugs' effectiveness against life-threatening diseases and restore the efficacy of defunct antibiotics.
LTech Lims1 Risk Management standalone module
01 December, 2017 | Supplied by: LTech Australia Pty LtdLTech presents its latest standalone module, Lims1 Risk Management, specifically designed for laboratories wanting to achieve management of risks and compliance.
New tool to better share clinico-genomic data
23 November, 2017Spanish researchers have developed a new tool that enables clinico-genomic data to be easily shared among different institutions.
LTech Lims1 Emergent LIMS
01 November, 2017 | Supplied by: LTech Australia Pty LtdLTech presents its latest laboratory information management system (LIMS), specifically designed for budget-conscious labs — Lims1 Emergent.
Big data provides insights into cardiovascular care post-hospitalisation
25 October, 2017Cardiologists are collaborating on a groundbreaking study into cardiovascular care, using over 100 million healthcare records from more than 1000 hospitals.
Abbott AlinIQ CDS Expert
05 October, 2017 | Supplied by: Abbott Australasia Pty LtdAbbott's AlinIQ CDS Expert allows clinicians, pathologists and relevant experts to capture their intellectual property and decision-making processes in a case-based and rule-based solution.
Improving efficiency with LIMS
03 October, 2017 | Supplied by: LTech Australia Pty LtdAn Australian developer and distributor of laboratory informatics software solutions, LTech, was recently asked to design a laboratory information management software for emerging labs to help them improve operational and cost efficiencies.
Bitplane Imaris v9.0 3D/4D image analysis software
01 October, 2017 | Supplied by: SciTech Pty LtdAvailable for Windows and Mac, the Imaris product line offers what is claimed to be the most powerful and versatile 3D and 4D imaging analysis software solution on the market for researchers in life sciences, medicine and related fields.
Data management delays negatively impacting trials
29 September, 2017Electronic data capture (EDC) may be gaining traction in the clinical trials market but companies face a growing number of challenges building and managing study databases, according to a study by Tufts Center for the Study of Drug Development.
